These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 31136988)
1. miR-21 regulates growth and EMT in lung cancer cells via PTEN/Akt/GSK3β signaling. Dai L; Chen F; Zheng Y; Zhang D; Qian B; Ji H; Long F; Cretoiu D Front Biosci (Landmark Ed); 2019 Jun; 24(8):1426-1439. PubMed ID: 31136988 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
3. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway. Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974 [TBL] [Abstract][Full Text] [Related]
4. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer. Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer. Ling C; Wang X; Zhu J; Tang H; Du W; Zeng Y; Sun L; Huang JA; Liu Z Cancer Med; 2019 Jul; 8(7):3520-3531. PubMed ID: 31074594 [TBL] [Abstract][Full Text] [Related]
6. Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer. Zhao M; Xu P; Liu Z; Zhen Y; Chen Y; Liu Y; Fu Q; Deng X; Liang Z; Li Y; Lin X; Fang W Cell Death Dis; 2018 Jan; 9(2):78. PubMed ID: 29362431 [TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro. Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487 [TBL] [Abstract][Full Text] [Related]
8. Cypripedin diminishes an epithelial-to-mesenchymal transition in non-small cell lung cancer cells through suppression of Akt/GSK-3β signalling. Treesuwan S; Sritularak B; Chanvorachote P; Pongrakhananon V Sci Rep; 2018 May; 8(1):8009. PubMed ID: 29789636 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway. Song L; Li D; Gu Y; Wen ZM; Jie J; Zhao D; Peng LP Clin Lung Cancer; 2016 Sep; 17(5):e65-e75. PubMed ID: 27236384 [TBL] [Abstract][Full Text] [Related]
10. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
11. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling. Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247 [TBL] [Abstract][Full Text] [Related]
12. miR-205 regulates A549 cells proliferation by targeting PTEN. Bai J; Zhu X; Ma J; Wang W Int J Clin Exp Pathol; 2015; 8(2):1175-83. PubMed ID: 25973003 [TBL] [Abstract][Full Text] [Related]
13. Analysis of miRNA profiles identified miR-196a as a crucial mediator of aberrant PI3K/AKT signaling in lung cancer cells. Guerriero I; D'Angelo D; Pallante P; Santos M; Scrima M; Malanga D; De Marco C; Ravo M; Weisz A; Laudanna C; Ceccarelli M; Falco G; Rizzuto A; Viglietto G Oncotarget; 2017 Mar; 8(12):19172-19191. PubMed ID: 27880728 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling. Tao JL; Luo M; Sun H; Zhao HM; Sun QS; Huang ZM Kaohsiung J Med Sci; 2020 Jun; 36(6):417-422. PubMed ID: 32052576 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer. Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281 [TBL] [Abstract][Full Text] [Related]
16. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells. Perumal E; So Youn K; Sun S; Seung-Hyun J; Suji M; Jieying L; Yeun-Jun C Lung Cancer; 2019 Apr; 130():25-34. PubMed ID: 30885348 [TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer. Khandelwal A; Seam RK; Gupta M; Rana MK; Prakash H; Vasquez KM; Jain A Cancer Sci; 2020 Mar; 111(3):826-839. PubMed ID: 31520555 [TBL] [Abstract][Full Text] [Related]
18. miR-1297 Promotes Cell Proliferation of Non-Small Cell Lung Cancer Cells: Involving in PTEN/Akt/Skp2 Signaling Pathway. Bu W; Luo T DNA Cell Biol; 2017 Nov; 36(11):976-982. PubMed ID: 28872922 [TBL] [Abstract][Full Text] [Related]
19. CircLIFRSA/miR-1305/PTEN axis attenuates malignant cellular processes in non-small cell lung cancer by regulating AKT phosphorylation. Jiang M; Bai H; Fang S; Zhou C; Shen W; Gong Z Mol Cancer; 2024 Sep; 23(1):208. PubMed ID: 39342185 [TBL] [Abstract][Full Text] [Related]
20. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene. Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]